-
Celgene Corporation v. Breckenridge Pharmaceutical, Inc. et al DC
- 2:19-cv-05804
- D.N.J.
- Judge: Esther Salas
+1
- Filed: 02/14/2019
- Closed: 10/28/2020
- Latest Docket Entry: 01/25/2021
- PACER
- Docket updated daily
1
Plaintiff
3
Defendants
4
Accused
Products
3
Patents-in-Suit
623
Days in
Litigation
-
Celgene Corporation v. Breckenridge Pharmaceutical, Inc. et al DC
- 2:19-cv-05804
- D.N.J.
- Judge: Esther Salas
+1
- Filed: 02/14/2019
- Closed: 10/28/2020
- Latest Docket Entry: 01/25/2021
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Breckenridge Pharmaceutical, Inc.
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 1 mg POMALYST drug products2 mg POMALYST drug products3 mg POMALYST drug products4 mg POMALYST drug products | US 10,093,647 B1 | All Asserted Claims |
No infringement
Entry 117
|
| 1 mg POMALYST drug products2 mg POMALYST drug products3 mg POMALYST drug products4 mg POMALYST drug products | US 10,093,648 B1 | All Asserted Claims |
No infringement
Entry 117
|
| 1 mg POMALYST drug products2 mg POMALYST drug products3 mg POMALYST drug products4 mg POMALYST drug products | US 10,093,649 B1 | All Asserted Claims |
No infringement
Entry 117
|
